Amicus Therapeutics US, LLC v. Teva Pharmaceuticals USA, Inc

Court

District Court, D. Delaware (D. Del.)
Official Court Website →

Assigned judge

Christopher J. Burke · 88 cases in index

Docket number

1:22-cv-01461

Cause

35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement

Nature of suit

835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal Question

Jury demand

None

Date filed

11/07/2022

1,113 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Amicus Therapeutics US, LLC · 8 cases
• defendant · Teva Pharmaceuticals USA, Inc · 782 cases

Part of a Larger Litigation Pattern

This is one of 783 Patent - ANDA cases in our index naming TEVA PHARMACEUTICALS USA, INC — a possible mass-tort or coordinated-litigation cluster.

• Amicus Therapeutics US, LLC v. Teva Pharmaceuticals USA, Inc
  District Court, D. DelawareFiled 06/13/2024
• Bayer Pharma Ag v. Teva Pharmaceuticals USA, Inc
  District Court, D. DelawareFiled 05/19/2023
• Corcept Therapeutics, Inc v. Teva Pharmaceuticals USA, Inc
  District Court, D. New JerseyFiled 03/17/2023
• Vifor Fresenius Medical Care Renal Pharma Ltd v. Teva Pharmaceuticals USA, Inc
  District Court, D. DelawareFiled 09/21/2022
• Otsuka Pharmaceutical Co., Ltd v. Teva Pharmaceuticals USA, Inc
  District Court, D. DelawareFiled 02/18/2022
• Pfizer Inc v. Teva Pharmaceuticals USA, Inc
  District Court, D. DelawareFiled 02/11/2022

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Amicus Therapeutics US, LLC v. Teva Pharmaceuticals USA, Inc?

Amicus Therapeutics US, LLC v. Teva Pharmaceuticals USA, Inc is a federal patent - anda lawsuit filed on 11/07/2022 in the District Court, D. Delaware. The case is currently open in the federal court system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. Delaware, docket number 1:22-cv-01461.

When was the case filed?

Amicus Therapeutics US, LLC v. Teva Pharmaceuticals USA, Inc was filed on 11/07/2022. The case is currently open.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.